We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.19%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.14%
2 Technology 18.23%
3 Financials 11.1%
4 Healthcare 10.5%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XSMO icon
1351
Invesco S&P SmallCap Momentum ETF
XSMO
$2.91B
$224K ﹤0.01%
4,205
+218
+5% +$11.5K
CCJ icon
1352
Cameco
CCJ
$40B
$223K ﹤0.01%
10,265
-427
-4% -$8.08K
CGC
1353
Canopy Growth
CGC
$391M
$223K ﹤0.01%
1,605
-317
-16% -$56.8K
RIGL icon
1354
Rigel Pharmaceuticals
RIGL
$845M
$223K ﹤0.01%
6,139
-20,057
-77% -$789K
MMU
1355
Western Asset Managed Municipals Fund
MMU
$513M
$222K ﹤0.01%
16,639
+12
+0.1% +$163
WGO icon
1356
Winnebago Industries
WGO
$786M
$221K ﹤0.01%
3,052
-5,504
-64% -$385K
RCI icon
1357
Rogers Communications
RCI
$19.5B
$220K ﹤0.01%
4,700
VOE icon
1358
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.9B
$220K ﹤0.01%
1,575
+46
+3% +$6.53K
WRB icon
1359
W.R. Berkley
WRB
$26.3B
$220K ﹤0.01%
6,750
VBIV
1360
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$220K ﹤0.01%
2,364
-134
-5% -$12.7K
IVH
1361
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
$220K ﹤0.01%
16,100
CPB icon
1362
Campbell Soup
CPB
$6.48B
$219K ﹤0.01%
5,227
-20
-0.4% -$868
OSIS icon
1363
OSI Systems
OSIS
$3.25B
$218K ﹤0.01%
+2,300
New +$224K
AFG icon
1364
American Financial Group
AFG
$12B
$217K ﹤0.01%
1,728
+105
+6% +$13.7K
BLDP
1365
Ballard Power Systems
BLDP
$633M
$216K ﹤0.01%
15,390
-100
-0.6% -$1.58K
AUB icon
1366
Atlantic Union Bankshares
AUB
$5.67B
$215K ﹤0.01%
5,824
CTSH icon
1367
Cognizant
CTSH
$28.2B
$214K ﹤0.01%
+2,883
New +$213K
FWONK icon
1368
Liberty Media Series C
FWONK
$24B
$214K ﹤0.01%
4,303
-42
-1% -$1.99K
ACHV icon
1369
Achieve Life Sciences
ACHV
$765M
$213K ﹤0.01%
25,000
+2,000
+9% +$15.7K
AVK
1370
Advent Convertible and Income Fund
AVK
$526M
$213K ﹤0.01%
+12,146
New +$226K
PUBM icon
1371
PubMatic
PUBM
$764M
$213K ﹤0.01%
8,095
+2,808
+53% +$84.2K
EMLP icon
1372
First Trust North American Energy Infrastructure Fund
EMLP
$4.11B
$212K ﹤0.01%
8,951
RF icon
1373
Regions Financial
RF
$24.9B
$212K ﹤0.01%
9,941
-18,273
-65% -$364K
VXX icon
1374
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$131M
$211K ﹤0.01%
+473
New +$212K
AGNT
1375
AGNT Inc
AGNT
$658M
$210K ﹤0.01%
+5,292
New +$227K

Similar funds

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.